Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease
Open Access
- 1 April 2004
- Vol. 59 (4) , 318-323
- https://doi.org/10.1136/thx.2003.014902
Abstract
Background: In patients with cystic fibrosis (CF) neutrophils are recruited in excess to the airways yet pathogens are not cleared and the patients suffer from chronic infections. Recent studies have shown a deficiency in airway fluids from patients with CF and other inflammatory pulmonary conditions of surfactant protein A (SP-A), a pattern recognition molecule that facilitates uptake of microbes by macrophages and neutrophils. Methods: In vitro simulations were used to test the hypothesis that decreased SP-A levels in CF might be the result of degradation by neutrophil serine proteases. Results: Very low levels of the neutrophil granule serine proteases cathepsin G, elastase, and proteinase-3 rapidly degraded pure SP-A when tested in buffered saline. The order of potency was cathepsin G>elastase>proteinase-3. The addition of cathepsin G or elastase to normal bronchoalveolar lavage (BAL) fluid caused a dose dependent degradation of endogenous native SP-A. Cathepsin G and elastase were present in the BAL fluid from many patients with CF. Simple incubation of protease positive BAL fluid from patients with CF caused a time dependent degradation of added SP-A or, where present, endogenous SP-A. The degradation of SP-A by protease(s) in BAL fluid of patients with CF was abrogated by diisopropylfluorophosphate and monocyte/neutrophil elastase inhibitor. Conclusions: The findings strongly suggest that the neutrophil serine proteases cathepsin G and/or elastase and/or proteinase-3 contribute to degradation of SP-A and thereby diminish innate pulmonary antimicrobial defence.Keywords
This publication has 35 references indexed in Scilit:
- The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lungJournal of Clinical Investigation, 2002
- Quantum proteolysis by neutrophils: implications for pulmonary emphysema in α1-antitrypsin deficiencyJournal of Clinical Investigation, 1999
- Introduction of Mannose Binding Protein-Type Phosphatidylinositol Recognition into Pulmonary Surfactant Protein ABiochemistry, 1999
- CALCIUM-DEPENDENT DEGRADATION OF SURFACTANT PROTEIN A BY ACTIVATED NEUTROPHILS DUE TO SERINE PROTEASESExperimental Lung Research, 1999
- Surfactant content in children with inflammatory lung diseaseCritical Care Medicine, 1996
- Epitope mapping for monoclonal antibody against human surfactant protein A (SP-A) that alters receptor binding of SP-A and the SP-A-dependent regulation of phospholipid secretion by alveolar type II cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitorsEuropean Respiratory Journal, 1995
- Collectins: pattern recognition molecules involved in first line host defenseCurrent Opinion in Immunology, 1993
- Aerosol α1 -antitrypsin treatment for cystic fibrosisThe Lancet, 1991
- Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastaseBiochimica et Biophysica Acta (BBA) - General Subjects, 1989